Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020505 (
hyperphagia
)
6,116
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. We have confirmed the Diabetes Mellitus OLETF type I (Dmo1) effect on
hyperphagia
, dyslipidaemia and obesity in the Otsuka Long-Evans Tokushima Fatty (OLETF) strain. The critical interval was narrowed down to 570 kb between D1Got258 to p162CA1 by segregation analyses using congenic lines. 2. Within the critical 570 kb region of the Dmo1 locus, we identified the G-protein-coupled receptor gene
GPR10
as the causative gene mutated in the OLETF strain. The ATG translation initiation codon of
GPR10
is changed into ATA in this strain and, so, is unavailable for the initiation of translation. 3. The
GPR10
protein has a cognate ligand, namely prolactin-releasing peptide (PrRP). Centrally administered PrRP suppressed the food intake of congenic rats that have a Brown Norway derived Dmo1 region (i.e. with wild-type
GPR10
), but did not suppress that of the OLETF strain, indicating that
GPR10
is without function and could explain
hyperphagia
in the OLETF strain. 4. Moreover, when restricted in food volume to the same level consumed by the congenic strain, OLETF rats showed few differences in the parameters of dyslipidaemia and obesity compared with congenic strains. 5. Taken together, these results demonstrate that the mutated
GPR10
receptor is responsible for the
hyperphagia
leading to obesity and dyslipidaemia in the obese diabetic strain rat.
...
PMID:Mutated G-protein-coupled receptor GPR10 is responsible for the hyperphagia/dyslipidaemia/obesity locus of Dmo1 in the OLETF rat. 1585 42